WARF ADVANCES
Top licensing prospects from the University of Wisconsin-Madison
Enhancing Immune Checkpoint Blockade Therapy Against Hypoxic Tumors
This improved delivery system is able to penetrate the extracellular matrix and shuttle surface-conjugated protein cages, composed of collagenases and anti-PD-L1 antibodies, to cancerous cells including pancreatic tumors.
Read more
Monitoring Lesion Progression over Multiple Medical Scans
This method for assessing disease progression as revealed by multiple lesions between time-separated scans of a patient assesses overlap between all pairs in the scan sequence and links lesions in different images to maximize overlap globally.
Read more
Lipopeptides and Nanoparticles
UW-Madison researchers have developed a novel lipopeptide-based nanoparticle for efficient delivery of various biomolecules including plasmid DNA, messenger RNA and CRISPR Cas9 ribonucleoprotein.
Read more
Treating Cancer with Targeted Radionuclide Therapy and Dual CAR T Cell Therapy
A team of UW-Madison researchers has developed a new CAR T cell technology to be used in combination with targeted radionuclide treatment for treating solid tumors.
Read more
Enhancing Compliance in Small-Diameter Vascular Grafts
This advanced fabrication method for polytetrafluoroethylene (ePTFE) vascular grafts improves mechanical compliance between the graft and native tissue in small-diameter vascular grafts.
Read more
Activating Appendages to Induce Polypharmacology in Peptide Hormone Analogues
A team of chemists has developed a synthetic peptide that turns a peptide that binds one of the class B GPCRs into a dual agonist.
Read more
Read about more licensing prospects!
Featured UW-Madison Researcher
 |
Pallavi Tiwari, Associate Professor of Radiology
“Prof. Tiwari’s goal is to improve cancer diagnosis and treatment using AI to transform the health care experience. We’re proud to support her technologies to benefit patients worldwide.” – Jeanine Burmania, WARF Senior Director of IP and Licensing |
In the News